Cargando…
Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements
Recently, we demonstrated that hematopoietic stem/progenitor cell (HSPC) mobilization followed by intravenous injection of integrating, helper-dependent adenovirus HDAd5/35++ vectors resulted in efficient transduction of long-term repopulating cells and disease amelioration in mouse models after in...
Autores principales: | Wang, Hongjie, Georgakopoulou, Aphrodite, Li, Chang, Liu, Zhinan, Gil, Sucheol, Bashyam, Ashvin, Yannaki, Evangelia, Anagnostopoulos, Achilles, Pande, Amit, Izsvák, Zsuzsanna, Papayannopoulou, Thalia, Lieber, André |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455141/ https://www.ncbi.nlm.nih.gov/pubmed/32814708 http://dx.doi.org/10.1172/jci.insight.139538 |
Ejemplares similares
-
Safe and efficient in vivo hematopoietic stem cell transduction in nonhuman primates using HDAd5/35++ vectors
por: Li, Chang, et al.
Publicado: (2021) -
HDAd5/35(++) Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells
por: Li, Chang, et al.
Publicado: (2018) -
Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies
por: Li, Chang, et al.
Publicado: (2018) -
ThalPred: a web-based prediction tool for discriminating thalassemia trait and iron deficiency anemia
por: Laengsri, V., et al.
Publicado: (2019) -
Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
por: Psatha, Nikoletta, et al.
Publicado: (2018)